Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HARTFORD INSURANCE GROUP, INC.HIG · Entity 3092 | EVP and CFO | February 24, 2026 | February 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HARTFORD INSURANCE GROUP, INC.
Report date February 24, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $140.54 · Expires 2036-02-24 | Direct | 22,051 |
Reported balance
After 2026-02-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-24 · Grant · Acquired 22,051 · Balance 22,051 F1: One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $49.01 · Expires 2029-02-26 | Direct | 75,790 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 75,790 F2: The options became fully exercisable on February 26, 2022, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $51.87 · Expires 2031-02-23 | Direct | 67,204 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 67,204 F3: The options became fully exercisable on February 23, 2024, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $53.81 · Expires 2028-02-27 | Direct | 63,194 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 63,194 F4: The options became fully exercisable on February 27, 2021, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $55.27 · Expires 2030-02-25 | Direct | 71,318 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 71,318 F5: The options became fully exercisable on February 25, 2023, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $69.41 · Expires 2032-02-23 | Direct | 75,483 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 75,483 F6: The options became fully exercisable on February 23, 2025, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.28 · Expires 2033-02-28 | Direct | 57,492 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 57,492 F7: One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $95.74 · Expires 2034-02-27 | Direct | 25,223 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 25,223 F8: One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $116.41 · Expires 2035-02-25 | Direct | 21,847 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 21,847 F9: One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | Direct | 92,988.282 |
Reported balance
Holding disclosure · report date 2026-02-24 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 92,988.282 |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
F2: The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
F3: The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
F4: The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
F5: The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
F6: The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
F7: One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
F8: One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
F9: One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2018 Filed Mar 1, 2018 22:13 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | SaleCommon Stock | 2,399 | $54.23 | $130,100.17 |
DisclosureSEC source: 0001225208-18-004962 · doc4.xml · nonDerivative · entry 6 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,098.6 F1 · kind: Transaction effected pursuant to a pre-planned trading plan entered into on December 12, 2017 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $53.86 to $54.78 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:13 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | SaleCommon Stock | 200 | $54.83 | $10,966.00 |
DisclosureSEC source: 0001225208-18-004962 · doc4.xml · nonDerivative · entry 5 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,497.6 F1 · kind: Transaction effected pursuant to a pre-planned trading plan entered into on December 12, 2017 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: Price reflected is the weighted average sale price for shares sold. The range of sales prices for the transactions reported was $54.82 to $54.84 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:13 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionCommon Stock | 200 | $24.15 | $4,830.00 |
DisclosureSEC source: 0001225208-18-004962 · doc4.xml · nonDerivative · entry 4 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,697.6 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:13 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionCommon Stock | 2,399 | $20.63 | $49,491.37 |
DisclosureSEC source: 0001225208-18-004962 · doc4.xml · nonDerivative · entry 3 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,497.6 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:13 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionCommon Stock | 4,368 | $28.91 | $126,278.88 |
DisclosureSEC source: 0001225208-18-004962 · doc4.xml · nonDerivative · entry 2 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,098.6 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:13 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionCommon Stock | 16,938 | $24.15 | $409,052.70 |
DisclosureSEC source: 0001225208-18-004962 · doc4.xml · nonDerivative · entry 1 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,730.6 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 21:19 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionPerformance Shares · Derivative | 20,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004016 · doc4.xml · derivative · entry 4 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 21, 2018, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2015 through December 31, 2017 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.exercise_date: On February 21, 2018, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2015 through December 31, 2017 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.expiration_date: On February 21, 2018, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2015 through December 31, 2017 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 21:19 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | GrantPerformance Shares · Derivative | 20,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004016 · doc4.xml · derivative · entry 3 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,800 Underlying: Common Stock · 20,800 shares Expires not disclosed F1 · derivative.exercise_price: On February 21, 2018, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2015 through December 31, 2017 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.exercise_date: On February 21, 2018, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2015 through December 31, 2017 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.expiration_date: On February 21, 2018, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2015 through December 31, 2017 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 21:19 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionCommon Stock | 20,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004016 · doc4.xml · nonDerivative · entry 1 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,792.6 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 21, 2018, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2015 through December 31, 2017 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 21:11 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | GrantStock Option · Derivative | 70,679 | $0.00 Strike: $48.89 | $0.00 |
DisclosureSEC source: 0001225208-17-005294 · doc4.xml · derivative · entry 3 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,679 Underlying: Common Stock · 70,679 shares Expires 2027-02-28 F1 · derivative.exercise_date: One-third of the options will become exercisable on February 28, 2018, an additional one-third of the options will become exercisable on February 28, 2019 and the remaining one-third of the options will become exercisable on February 28, 2020, the third anniversary of the grant date. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 21:04 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Tax withholdingCommon Stock | 3,583 | $48.36 | $173,273.88 |
DisclosureSEC source: 0001225208-17-004716 · doc4.xml · nonDerivative · entry 1 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,993.779 F1 · kind: Transaction involving a disposition to the Company of equity securities to cover tax withholding obligations arising from the performance share certification reported on a Form 4 dated February 22, 2017, in accordance with the Company's administrative rules. F2 · price: The closing price of the Company's common stock on February 17, 2017, the last trading day prior to certification. Read SEC document |
| February 20, 2017 Filed Feb 22, 2017 21:04 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionPerformance Shares · Derivative | 7,256.6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-004092 · doc4.xml · derivative · entry 4 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,256.6 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 20, 2017, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2014 through December 31, 2016 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.exercise_date: On February 20, 2017, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2014 through December 31, 2016 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.expiration_date: On February 20, 2017, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2014 through December 31, 2016 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
| February 20, 2017 Filed Feb 22, 2017 21:04 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | GrantPerformance Shares · Derivative | 7,256.6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-004092 · doc4.xml · derivative · entry 3 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,256.6 Underlying: Common Stock · 7,256.6 shares Expires not disclosed F1 · derivative.exercise_price: On February 20, 2017, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2014 through December 31, 2016 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.exercise_date: On February 20, 2017, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2014 through December 31, 2016 performance period. The performance shares were paid in shares of the Company's common stock. F1 · derivative.expiration_date: On February 20, 2017, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2014 through December 31, 2016 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
| February 20, 2017 Filed Feb 22, 2017 21:04 UTC | HARTFORD INSURANCE GROUP, INC. HIG · Entity 3092 | Exercise / conversionCommon Stock | 7,256.6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-004092 · doc4.xml · nonDerivative · entry 1 Bombara Beth Ann · CIK 0001399852 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,576.779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 20, 2017, the Company's Compensation and Management Development Committee certified a performance share payout, based on the level of the Company's performance relative to pre-established objectives for the January 1, 2014 through December 31, 2016 performance period. The performance shares were paid in shares of the Company's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.